Mark DeLong - Feb 10, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Business & Strat Officer
Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Stock symbol
APLS
Transactions as of
Feb 10, 2023
Transactions value $
-$34,311
Form type
4
Date filed
2/14/2023, 03:24 PM
Previous filing
Jan 30, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$34.3K -670 -1.42% $51.21 46.5K Feb 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares withheld for tax on a restricted stock unit release.